Paradoxical Pyogenic Granuloma Associated With Ramucirumab but Not Bevacizumab: A Case Suggesting Differential Effects of VEGF Receptor and Ligand Inhibition
Akina Nigi, Keisuke Iwamoto, Hidetoshi Itani, Shigeto Kondou · 2026
Read Paradoxical Pyogenic Granuloma Associated With Ramucirumab but Not Bevacizumab: A Case Suggesting Differential Effects of VEGF Receptor and Ligand Inhibition by Akina Nigi, Keisuke Iwamoto, Hidetoshi Itani, Shigeto Kondou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13143411.txt.
Description
Akina Nigi and co-authors reported this 2026 case of a side effect that seems to contradict a cancer drug's purpose. The drug blocks blood vessel growth to starve tumors. Yet a 75-year-old man on the drug grew small vessel lumps that bled again and again. Tissue tests confirmed the lumps were benign growths called pyogenic granulomas.
The man had advanced lung cancer and took the drug with a second agent. The bleeding lumps hurt his daily life, so doctors cut them out and stopped the drug. He then switched to a sister drug that blocks the vessel signal rather than its receiver. No new lumps appeared. The contrast hints the two blocking styles differ in this rare risk, and the authors suggest a switch as a remedy.
Catalog record
| CREATOR | Akina Nigi, Keisuke Iwamoto, Hidetoshi Itani, Shigeto Kondou |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 10 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |